Turecky L, Kupcova V, Mojto V, Smutny M, Uhlikova E, Vozar I
Department of Medical Chemistry, Biochemistry and Clinical Biochemistry, Comenius University, Bratislava, Slovakia.
Bratisl Lek Listy. 2005;106(8-9):266-9.
Diabetes mellitus is associated with a lot of changes in intermediary metabolism and several authors reported on higher frequency of liver diseases in patients with diabetes.
Was to establish the changes of blood serum cholinesterase, prealbumin and albumin, parameters which are accepted as an index of liver proteosynthetic function, in patients with diabetes mellitus.
The study group consisted of 207 patients with diabetes mellitus (83 patients with type I and 124 patients with type II diabetes mellitus). Control group consisted of 179 healthy subjects. The activity of cholinesterase was assayed by the kinetic method, concentrations of prealbumin and albumin were determined immunochemically.
Activity of serum cholinesterase was significantly higher in group of patients with diabetes mellitus than in control group (65.05 vs 73.33 microkat/l). The concentration of prealbumin was lower in blood serum of patients with diabetes than in controls (308.10 vs 285.85 mg/l). Serum levels of albumin were not different in both studied groups. After dividing of patients according to the type of diabetes, 80 % of abnormal values of cholinesterase and prealbumin were present in patients with type II diabetes.
The results of our study showed abnormal values of determined liver tests approximately in 22 % of patients with diabetes mellitus. The character of laboratory changes--increased activity of cholinesterase, decreased concentration of prealbumin and normal levels of albumin, suggests development of liver steatosis in these patients. The most of pathological findings were in patients with diabetes type II (Tab. 3, Ref. 20).
糖尿病与中间代谢的许多变化有关,一些作者报道糖尿病患者肝病的发生率更高。
确定糖尿病患者血清胆碱酯酶、前白蛋白和白蛋白的变化,这些参数被视为肝脏蛋白质合成功能的指标。
研究组由207例糖尿病患者组成(83例I型糖尿病患者和124例II型糖尿病患者)。对照组由179名健康受试者组成。采用动力学方法测定胆碱酯酶活性,免疫化学法测定前白蛋白和白蛋白浓度。
糖尿病患者组血清胆碱酯酶活性显著高于对照组(65.05对73.33微卡/升)。糖尿病患者血清前白蛋白浓度低于对照组(308.10对285.85毫克/升)。两个研究组的血清白蛋白水平无差异。根据糖尿病类型对患者进行分组后,80%的胆碱酯酶和前白蛋白异常值出现在II型糖尿病患者中。
我们的研究结果显示,约22%的糖尿病患者肝脏检查结果异常。实验室变化的特征——胆碱酯酶活性增加、前白蛋白浓度降低和白蛋白水平正常,提示这些患者发生了肝脂肪变性。大多数病理结果出现在II型糖尿病患者中(表3,参考文献20)。